123 related articles for article (PubMed ID: 18666432)
1. A new class of isoxazole derivatives: the M 1-9 series of compounds with immunotropic activity.
Maczyński M; Zimecki M; Ryng S
Acta Pol Pharm; 2008; 65(2):241-4. PubMed ID: 18666432
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and immunological activity of new 5-amino-3-methyl 4-amido and 4-ureilene isoxazole derivatives.
Ryng S; Machoń Z; Wieczorek Z; Zimecki M
Pharmazie; 1999 May; 54(5):359-61. PubMed ID: 10368829
[TBL] [Abstract][Full Text] [Related]
3. Structure and immunological activity of disubstituted thiosemicarbazide isoxazole derivative.
Maczyński M; Zimecki M; Ryng S
Acta Pol Pharm; 2004 Dec; 61 Suppl():82-3. PubMed ID: 15909949
[TBL] [Abstract][Full Text] [Related]
4. In vitro immunomodulatory effects of 5-amino-3-methyl-4-isoxazolecarboxylic acid hydrazide on the cellular immune response.
Drynda A; Mączyński M; Ryng S; Obmińska-Mrukowicz B
Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):150-7. PubMed ID: 24588616
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, immunological activity and computational study of 5-amino-3-methyl-4-isoxazolecarboxylic acid semicarbazides and thiosemicarbazides.
Maczyński M; Zimecki M; Taraszkiewicz M; Ryng S
Acta Pol Pharm; 2008; 65(5):543-9. PubMed ID: 19051600
[TBL] [Abstract][Full Text] [Related]
6. The 5-amino-3-methyl-4-ureidoisoxazoles, synthesis and antileucemic activity.
Ryng S; Duś D
Pharmazie; 1994 Oct; 49(10):727-9. PubMed ID: 7816898
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological properties of 5-benzoylamino-3-methyl-4-isoxazolocarboxylic acid derivatives.
Machoń Z; Ryng S
Arch Immunol Ther Exp (Warsz); 1981; 29(6):813-21. PubMed ID: 7349102
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and immunomodulatory activites of new 5-hydrazino-3-methyl-4-isothiazolecarboxylic acid ethyl esters.
Lipnicka U; Maczyński M; Artym J; Zimecki M
Acta Pol Pharm; 2009; 66(5):501-11. PubMed ID: 19894646
[TBL] [Abstract][Full Text] [Related]
9. Search for new lead structures in the isoxazole heterocyclic system.
Ryng S; Zimecki M; Fedorowicz A; Jezierska A; Głowiak T
Acta Pol Pharm; 2003; 60(3):225-8. PubMed ID: 14556494
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytostatic properties of 5-substituted derivatives of 3-methylisoxazolo[5,4-d]1,2,3-triazine-4-ones and 3-methyl-5-triazene 4-isoxazolecarboxylic acid ethyl esters.
Ryng S; Malinka W; Duś D
Farmaco; 1997 Feb; 52(2):105-8. PubMed ID: 9181691
[TBL] [Abstract][Full Text] [Related]
11. Novel terphenyls and 3,5-diaryl isoxazole derivatives endowed with growth supporting and antiapoptotic properties.
Simoni D; Rondanin R; Baruchello R; Rizzi M; Grisolia G; Eleopra M; Grimaudo S; Di Cristina A; Pipitone MR; Bongiorno MR; Aricò M; Invidiata FP; Tolomeo M
J Med Chem; 2008 Aug; 51(15):4796-803. PubMed ID: 18620379
[TBL] [Abstract][Full Text] [Related]
12. 5-Amino-3-methyl-4-isoxazolecarboxylic acid hydrazide derivatives with in vitro immunomodulatory activities.
Drynda A; Obmińska-Mrukowicz B; Zaczyńska E; Zimecki M; Kochanowska I; Ryng S; Mączyński M
Chem Biol Drug Des; 2017 May; 89(5):705-713. PubMed ID: 27779824
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists.
Xin Z; Zhao H; Serby MD; Liu B; Schaefer VG; Falls DH; Kaszubska W; Colins CA; Sham HL; Liu G
Bioorg Med Chem Lett; 2005 Feb; 15(4):1201-4. PubMed ID: 15686942
[TBL] [Abstract][Full Text] [Related]
14. Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation.
Kaffy J; Pontikis R; Carrez D; Croisy A; Monneret C; Florent JC
Bioorg Med Chem; 2006 Jun; 14(12):4067-77. PubMed ID: 16510288
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure elucidation of 5-aminomethinimino-3-methyl-4-isoxazolecarboxylic acid phenylamides and their immunological activity.
Ryng S; Machoń Z; Wieczorek Z; Zimecki M; Głowiak T
Arch Pharm (Weinheim); 1997 Nov; 330(11):319-26. PubMed ID: 9431023
[TBL] [Abstract][Full Text] [Related]
16. Search for new lead structures for low-molecular-weight immune response modifiers.
Ryng S; Zimecki M
Acta Pol Pharm; 2004 Dec; 61 Suppl():78-81. PubMed ID: 15909948
[TBL] [Abstract][Full Text] [Related]
17. SYNTHESIS AND IMMUNOREGULATORY PROPERTIES OF SELECTED 5-AMINO-3-METHYL-4-ISOXAZOLECARBOXYLIC ACID BENZYLAMIDES.
Maczynski M; Artym J; Kocieba M; Sockacka-Cwikla A; Drozd-Szczygiel E; Ryng S; Zimecki M
Acta Pol Pharm; 2016 Sep; 73(5):1201-1211. PubMed ID: 29638060
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, lipophilicity and antimicrobial activity of new derivatives of thiosemicarbazides and 1,2,4-triazoline-5-thione.
Wujec M; Stefańska J; Siwek A; Tatarczak M
Acta Pol Pharm; 2009; 66(1):73-82. PubMed ID: 19226973
[TBL] [Abstract][Full Text] [Related]
19. Novel derivatives of ISO-1 as potent inhibitors of MIF biological function.
Balachandran S; Rodge A; Gadekar PK; Yadav VN; Kamath D; Chetrapal-Kunwar A; Bhatt P; Srinivasan S; Sharma S; Vishwakarma RA; Dagia NM
Bioorg Med Chem Lett; 2009 Aug; 19(16):4773-6. PubMed ID: 19592246
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Immunosuppressive Properties, and Mechanism of Action of a New Isoxazole Derivative.
Mączyński M; Borska S; Mieszała K; Kocięba M; Zaczyńska E; Kochanowska I; Zimecki M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29949951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
